LinkDoc's 'Savage Growth' in the Era of Medical Species Explosion

On December 15, 2017, the “2017 Top 100 Future Healthcare Companies” forum, themed “The Era of Species Explosion,” was held in Beijing. The event was guided by the China Association for the Promotion of Rehabilitation Technology Translation and Development, and organized by VCBeat and VCBeat.

The “2017 Top 100 Future Healthcare” Forum, leveraging the release of the Top 100 Future Healthcare List and the associated series of awards, convened the most active healthcare innovation enterprises, listed companies, financial institutions, and medical organizations from both China and abroad. Centered on the year’s hottest topics in the healthcare sector—including intelligent imaging, smart medical devices, chain clinics, and hospital innovation—the forum hosted over 20 parallel sessions to foster effective interaction and collaboration across the industry chain, thereby accelerating the rapid development of the most high-growth-potential sectors and enterprises.

After winning the “Most Promising Enterprise Award” on VCBeat’s 2016 “Top 100 Future Healthcare Companies” list last year, LinkDoc Technology once again took home two awards at this year’s “2017 Top 100 Future Healthcare Companies” forum: being named to the 2017 “Top 100 Future Healthcare Companies” list and receiving the “Innovative Enterprise of the Year” award.

Zhang Tianze, CEO of LinkDoc Technology

Theme of the Conference: “The Era of Species Explosion”In this era of species explosion, various specialized sectors within healthcare are unleashing new vitality. These emerging elements have been categorized into five major themes at this conference: Transformation of Healthcare Service Systems, Deep Evolution of Medical Technology Driven by Capital, The New Competitive Landscape of Healthcare Traffic Entry Points, The New Normal in Pharmaceutical and Medical Device Industries Driven by Policy, and Cross-Sector Collaboration and Integrated Growth in the Healthcare Industry. In recent years, a diverse array of startups has emerged within both domestic and international healthcare sectors, constituting what can be described as a “species explosion” in the healthcare industry.

For LinkDoc Technology, its growth trajectory in recent years can be described as a period of rapid, unregulated expansion during the “Cambrian explosion” of species within the medical industry. By the second half of 2017, LinkDoc Technology had provided big data solutions to more than 500 Grade A tertiary general and specialized hospitals, deeply processed nearly 2 million oncology research-grade medical records, helped integrate and clean over 10 million regional healthcare data entries, and processed more than 10 million medical imaging datasets, thereby generating truly high-quality, research-grade data.

LinkDoc Technology is currently developing medical AI products with independent Chinese intellectual property rights across multiple domains, including intelligent imaging diagnosis, intelligent pathological diagnosis, and assisted clinical care (encompassing assisted diagnosis, assisted treatment, and risk prediction).

In 2017, LinkDoc Technology established R&D, data operations, and artificial intelligence research centers in Beijing, Tianjin, and Guangzhou, respectively, while setting up offices in more than 20 provinces and municipalities across China. Over three years, LinkDoc built a cross-disciplinary team of nearly 1,000 professionals spanning healthcare, information technology, AI algorithm analytics, scientific research, and medical affairs, achieving “wild growth” during the era of explosive diversification in the healthcare industry.

Just two days ago, LinkDoc Technology received the “Top 10 Most Innovative Enterprises in China’s Greater Health Industry” award from Yiou for 2017.

“Top 100 Future Healthcare Companies” 2017 Annual Awards ((Click to view the original ranking)Judges, publicly selected from industry experts, investors, and entrepreneurial practitioners, cast their votes. The final selection is jointly conducted by the VCBeat Content Center, Eggshell Research Institute, and industry judges. The awards are presented in three major categories: “Innovative Enterprises,” “Investment,” and “Industry Chain,” featuring multiple annual grand prizes such as “Listed Company of the Year for Driving Force,” “Innovative Enterprise of the Year,” “High-Potential Enterprise of the Year,” “Investment Firm of the Year,” and “Best Investor of the Year.”

From today’s perspective, the development of the global healthcare industry has become an unstoppable trend, a consensus shared both within China and internationally. Technological advancements have emerged as one of the dominant forces driving transformation in the healthcare sector.

In the future, artificial intelligence will profoundly influence and enhance our healthcare services; an increasing number of pharmaceuticals and medical devices will become more intelligent and personalized; long-accumulated medical data within hospitals will be revitalized through technologies such as big data integration systems, thereby enabling more precise diagnosis and treatment for both physicians and patients.

By deeply cultivating medical big data, LinkDoc Technology has continuously advanced its medical artificial intelligence capabilities and facilitated the practical implementation of cutting-edge technologies, thereby earning numerous prestigious industry accolades. Leveraging IT, internet technologies, big data, and artificial intelligence, LinkDoc Technology is committed to progress in the medical field, striving to lead China’s medical AI sector both now and in the future, while ensuring that its innovations benefit every patient in China.